Mefloquine shortage
Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) continues
Neon Healthcare have advised NaTHNaC that 250mg mefloquine (Lariam) antimalarial tablets are currently out of stock in the UK. A delivery is expected between October and December 2026.
Advice for health professionals
Clinics and pharmacies with remaining supplies of mefloquine should prioritise travellers with imminent travel for whom mefloquine is the first choice of antimalarial. This includes pregnant travellers visiting high risk malaria regions such as Sub-Saharan Africa.
Travellers who can take alternative antimalarials should be prescribed these, in order to preserve mefloquine supplies for those who cannot use other options.
Country specific advice about malaria risks and antimalarial recommendations available from the TravelHealthPro Country Information pages.
The UK Malaria Expert Advisory Group (UKMEAG) Malaria prevention guidelines for travellers from the UK provide detailed malaria advice and guidance for health professionals advising travellers and are the first port of call for queries.
Alternative suppliers
The following specialist importers have confirmed they can source unlicensed mefloquine 250 mg tablets (please note there may be other companies that can also source supplies):
- Alium
- Chemys
- Genetech
- Smartway
- Target Healthcare
Any decision to prescribe an unlicensed medicine must consider the relevant guidance and NHS Trust or local governance procedures. Unlicensed imports do not undergo any central quality assessment or suitability evaluation. Therefore, any import must be locally assessed in line with local unlicensed medicines processes. Please see the resources section below for further information.
If attempts to source mefloquine for an individual traveller are not successful, health professionals can contact NaTHNaC's telephone advice line for further advice.
The UK Health Security Agency Malaria Reference Laboratory offers an email advisory service for health professionals for complex queries which cannot be answered after consulting the Malaria prevention guidelines for travellers from the UK.
Resources
- Vaccines and medicines: availability, supply, shortages and use of unlicensed medicines – Information for health professionals on availability of vaccines and use of unlicensed products
- Medicines and Healthcare products Regulatory Agency (MHRA): The supply of unlicensed medicinal products
- Royal Pharmaceutical Society (RPS): Professional Guidance for the Procurement and Supply of Specials, Royal Pharmaceutical Society (RPS)
- General Medical Council (GMC): Prescribing unlicensed medicines, General Medical Council (GMC)
-
Mefloquine shortage continues; supplies expected to resume between October and December 2026.
-
Mefloquine shortage continues; supplies expected to resume between July and September 2026.
-
Shortage expected until the end of May 2026.
-
Shortage expected until the end of April 2026.
-
Shortage expected until the end of March 2026.
-
Alternative suppliers and additional references added.
Explore more
Celebrating Diwali abroad?
Reduce your risk of injury and illness while celebrating Diwali by following our travel health advice
Updated: 12 November 2026Help us to adapt a Travel Health Resource for UK Travellers
Take part in a study that aims to help UK travellers make informed choices about Japanese encephalitis (JE) vaccination
Updated: 26 October 2026Heading to the Youth Olympic Games in Senegal, West Africa, this autumn?
Make sure you are protected – get the right travel advice, vaccines and malarial tablets before you travel!
Updated: 12 November 2026Updated dengue 'green book' chapter published
The dengue chapter of the 'green book' (Immunisation against infectious disease) has been updated
Updated: 18 November 2026
